Tim Shadyac is a director in the Government Affairs Group, where he assists clients with legislative and regulatory issues. Tim’s areas of focus include the implementation of the Affordable Care Act and other health reform efforts, the Medicare program, drug pricing policy, and the broad impact of politics on health care policy.
Tim has experience working in a variety of health care sector settings. Prior to joining Crowell & Moring, Tim advised clients on a number of health care policy issues at Avalere Health, a D.C.-based health policy consultancy. Throughout his time at Avalere, Tim specialized in matters of importance to the life sciences industry and worked closely with various patient advocacy groups. His work was largely concentrated on issues related to the outcome of presidential and congressional elections, drug pricing policy, and Medicare Part D benefit design. Tim also served in the federal government affairs, public policy, and advocacy groups at Sanofi for nearly four years. There, he monitored and analyzed federal health policy to assess the business impact and developed strategies for response. In his role with the advocacy group, Tim sought opportunities to reflect the patient voice in regulatory guidance and identified opportunities for partnership with patient advocates.
Tim earned his B.A. in political science from Kenyon College.
Speeches & Presentations
-
"Update on the Trump China Tariffs - What is Going On?" Crowell & Moring Webinar
(May 17, 2019).
Presenters: James G. Flood, John B. Brew, Aaron Marx, Clark Jennings, W. Scott Douglas, and Tim Shadyac.
Client Alerts & Newsletters
-
"The Congressional Election and What It Means for 2019,"
Regulatory Alert
(November 20, 2018).
Contacts: James G. Flood, W. Scott Douglas, Jerrica Mathis, Tim Shadyac, Byron R. Brown
-
"Overview of the Senate Republican ACA Repeal and Replace Bill,"
(June 23, 2017).
Contacts: James G. Flood, W. Scott Douglas, Tim Shadyac